Finally, another meta-analysis of 22 case-control observational studies has found that IL-6 was higher in patients with LC compared with healthy individuals and those without post-acute sequelae of COVID-19 but lower than in patients during the acute phase of COVID-19 [173]. The gene discussed is IL6; the disease is laryngotracheoesophageal cleft.